Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Methods in Molecular Medicine|June 22, 2005
Southern blotting of IgH rearrangements in B-cell disordersEdna Yuen, Ross D BrownMethods in Molecular Medicine|June 22, 2005
Identification of malignant plasma cells by mRNA in situ hybridizationRoss D Brown, P Joy HoClinical Lymphoma & Myeloma|October 16, 2008
Regulatory T cells and multiple myelomaDouglas E Joshua, Ross D Brown, P Joy Ho, et al.International Journal of Oncology|May 14, 2016
Multiple myeloma and persistence of drug resistance in the age of novel drugs (Review)Sabna Rajeev Krishnan, Ritu Jaiswal, Ross D Brown, et al.Neoplasia (New York, N.Y.)|January 26, 2016
Isolation of Human CD138(+) Microparticles from the Plasma of Patients with Multiple MyelomaSabna Rajeev Krishnan, Frederick Luk, Ross D Brown, et al.The Medical Journal of Australia|January 19, 2011
The impact of mandatory fortification of flour with folic acid on the blood folate levels of an Australian populationRoss D Brown, Mark R Langshaw, Elaine J Uhr, et al.Leukemia & Lymphoma|February 15, 2012
Thalidomide consolidation improves progression-free survival in myeloma with normal but not up-regulated expression of fibroblast growth factor receptor 3: analysis from the Australasian Leukaemia and Lymphoma Group MM6 clinical trialP Joy Ho, Ross D Brown, Andrew Spencer, et al.Leukemia & Lymphoma|October 21, 2003
Prediction of high affinity class I-restricted multiple myeloma idiotype peptide epitopesDaniel M Y Szea, Ross D Brown, Shihong Yang, et al.Leukemia & Lymphoma|November 4, 2009
Prognostically significant cytotoxic T cell clones are stimulated after thalidomide therapy in patients with multiple myelomaRoss D Brown, Andrew Spencer, Phoebe Joy Ho, et al.Leukemia & Lymphoma|December 25, 2003
Clonal cytotoxic T cells in myelomaDaniel M Y Sze, Ross D Brown, Edna Yuen, et al.Pageof 2